<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01786278</url>
  </required_header>
  <id_info>
    <org_study_id>EGC-DYS-0254/281/2011-MUL</org_study_id>
    <secondary_id>MULEK-0254/281/2011</secondary_id>
    <nct_id>NCT01786278</nct_id>
  </id_info>
  <brief_title>Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer</brief_title>
  <acronym>BRASTEGAC</acronym>
  <official_title>The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St Johns' Oncology Center in Lublin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is comparison of the efficacy and safety of palliative therapy
      with single-dose brachytherapy or selfexpanding metal stents (SEMS) in malignant dysphagia
      resulting from adenocarcinoma of the esophago-gastric junction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the past two decades it has been observed a clear trend in the increasing incidence of
      adenocarcinoma of the esophagus and esophago-gastric junction. More than half of these
      patients already have inoperable disease at presentation. Most of them need palliative
      treatment to relieve progressive dysphagia. Presently, endoscopic placement of a covered
      selfexpanding metal stent is the most commonly used method for treatment of malignant
      dysphagia. Cancer overgrowth and stent migration are the most common complications of
      endoscopic stenting and they occur more frequently with longer time from stenting. Specific
      location at esophago-gastric junction at the end point of the propulsive force after swallow
      may predispose stents for easier migration to the stomach. Additionally, the advances in
      chemotherapy have resulted in improved median survival of advanced adenocarcinoma ot the
      stomach and esophago-gastric junction even up to 10-12 months increasing a potential for
      higher chance for occurrence of stent complications. Brachytherapy has been proved to be a
      valuable and durable method to treat malignant dysphagia resulting from esophageal and mainly
      squamous cell cancer. For many years irradiation was not recommended for adenocarcinoma of
      the esophagus and esophago-gastric junction due to their putative low sensitivity to
      radiotherapy. Recently external beam radiation has been incorporated to a combined modality
      therapy regimens also for adenocarcinoma of the esophagus. Thus, brachytherapy could be an
      attractive and durable method for improving swallowing in adenocarcinoma of the
      esophago-gastric junction, as well. Single-dose brachytherapy and endoscopic stenting with
      SEMS in relieving dysphagia resulting from clearly defined adenocarcinoma of the
      esophago-gastric junction have not been compared yet.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The highest improvement of dysphagia grade</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to the best swallowing improvement</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to recurrent worsening of swallowing</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The highest improvement of stricture diameter</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the procedure related morbidity</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the procedure related mortality</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The frequency of dysphagia related additional endoscopic interventions</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Cost analysis</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Adenocarcinoma of the Esophago-gastric Junction</condition>
  <arm_group>
    <arm_group_label>Brachytherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of 12 Gy generated using a flexible applicator containing Iridium 192 with the range of irradiation of 1cm from the applicator axis. The extent of irradiation will cover the whole length of cancer stricture and 2cm beyond proximal and distal end of the tumor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic Stenting</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Endoscopic stenting with partially covered selfexpandable metalic stents positioned across the cancer stricture and extending 2cm proximally and 2cm distally to the proximal and distal end of the tumor, respectively</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Brachytherapy</intervention_name>
    <description>Single dose of 12 Gy generated using a flexible applicator containing Iridium 192 with the range of irradiation of 1cm from the applicator axis. The extent of irradiation will cover the whole length of cancer stricture and 2cm beyond proximal and distal end of the tumor.</description>
    <arm_group_label>Brachytherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic stenting</intervention_name>
    <description>Endoscopic stenting with partially covered selfexpandable metalic stents positioned across the cancer stricture and extending 2cm proximally and 2cm distally to the proximal and distal end of the tumor, respectively</description>
    <arm_group_label>Endoscopic Stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adenocarcinoma of the esophago-gastric junction defined as adenocarcinoma involving
             lower esophagus and upper stomach with epicenter of the primary tumor between 5cm
             above and 5cm below the anatomic esophago-gastric junction

          -  Inoperable cancer - locally advanced irresectible cancer, distant metastasis or
             patient's condition does not fit to undergo a curative therapy

          -  Dysphagia score 2-4

          -  Performance status 60-100

          -  Signed informed consent

        Exclusion Criteria:

          -  Esophageal squamous cell carcinoma

          -  Esophageal adenocarcinoma

          -  Gastric cancer

          -  Performance status &lt;60

          -  Instable cardiocirculatory or respiratory disorder

          -  Concurrent external beam radiation therapy

          -  Previous anticancer therapy related to current adenocarcinoma of the esophago-gastric
             junction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Skoczylas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Department of General &amp; Gastrointestinal Surgery &amp; Surgical Oncology of the Alimentary Tract, Medical University of Lublin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krzysztof Zinkiewicz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Department of General &amp; Gastrointestinal Surgery &amp; Surgical Oncology of the Alimentary Tract, Medical University of Lublin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grzegorz Wallner, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Department of General &amp; Gastrointestinal Surgery &amp; Surgical Oncology of the Alimentary Tract, Medical University of Lublin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elżbieta Starosławska, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Johns' Oncology Center in Lublin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dariusz Kieszko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Johns' Oncology Center in Lublin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomasz Skoczylas, MD, PhD</last_name>
    <phone>+48 81 5328810</phone>
    <email>tomskocz@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Department of General &amp; Gastrointestinal Surgery &amp; Oncological Surgery of the Alimantary Tract, Medical University of Lublin</name>
      <address>
        <city>Lublin</city>
        <state>Lubelskie</state>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Skoczylas, MD, PhD</last_name>
      <phone>+48 81 5328810</phone>
      <email>tomskocz@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Tomasz Skoczylas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krzysztof Zinkiewicz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Witold Zgodziński, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marek Majewski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grzegorz Wallner, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrzej Dąbrowski, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Witold Krupski, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John's Cancer Center</name>
      <address>
        <city>Lublin</city>
        <state>Lubelskie</state>
        <zip>20-090</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dariusz Kieszko, MD, PhD</last_name>
      <phone>+48 81 7477511</phone>
      <phone_ext>142</phone_ext>
    </contact>
    <investigator>
      <last_name>Elżbieta Starosławska, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dariusz Kieszko, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paweł Cisek, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krzysztof Paprota, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Kubiatowski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bożena Kukiełka-Budny, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2013</study_first_submitted>
  <study_first_submitted_qc>February 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2013</study_first_posted>
  <last_update_submitted>February 5, 2013</last_update_submitted>
  <last_update_submitted_qc>February 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Tomasz Skoczylas</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>adenocarcinoma</keyword>
  <keyword>esophago-gastric junction</keyword>
  <keyword>dysphagia</keyword>
  <keyword>brachytherapy</keyword>
  <keyword>endoscopic stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Deglutition Disorders</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

